These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach. Beig M; Oellien F; Garoff L; Noack S; Krauth-Siegel RL; Selzer PM PLoS Negl Trop Dis; 2015; 9(6):e0003773. PubMed ID: 26042772 [TBL] [Abstract][Full Text] [Related]
29. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. Saravanamuthu A; Vickers TJ; Bond CS; Peterson MR; Hunter WN; Fairlamb AH J Biol Chem; 2004 Jul; 279(28):29493-500. PubMed ID: 15102853 [TBL] [Abstract][Full Text] [Related]
31. 8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase. Zani CL; Fairlamb AH Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):565-8. PubMed ID: 12937775 [TBL] [Abstract][Full Text] [Related]
32. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489 [TBL] [Abstract][Full Text] [Related]
33. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead. Chan C; Yin H; McKie JH; Fairlamb AH; Douglas KT Amino Acids; 2002 Jun; 22(4):297-308. PubMed ID: 12107758 [TBL] [Abstract][Full Text] [Related]
34. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase. Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds. Eberle C; Burkhard JA; Stump B; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F ChemMedChem; 2009 Dec; 4(12):2034-44. PubMed ID: 19847846 [TBL] [Abstract][Full Text] [Related]
36. 2-Amino diphenylsulfides as inhibitors of trypanothione reductase: modification of the side chain. Baillet S; Buisine E; Horvath D; Maes L; Bonnet B; Sergheraert C Bioorg Med Chem; 1996 Jun; 4(6):891-9. PubMed ID: 8818240 [TBL] [Abstract][Full Text] [Related]
37. Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness. Koh CY; Kim JE; Wetzel AB; de van der Schueren WJ; Shibata S; Ranade RM; Liu J; Zhang Z; Gillespie JR; Buckner FS; Verlinde CL; Fan E; Hol WG PLoS Negl Trop Dis; 2014 Apr; 8(4):e2775. PubMed ID: 24743796 [TBL] [Abstract][Full Text] [Related]
38. Parasite-specific trypanothione reductase as a drug target molecule. Krauth-Siegel RL; Inhoff O Parasitol Res; 2003 Jun; 90 Suppl 2():S77-85. PubMed ID: 12709793 [TBL] [Abstract][Full Text] [Related]
39. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. Martyn DC; Jones DC; Fairlamb AH; Clardy J Bioorg Med Chem Lett; 2007 Mar; 17(5):1280-3. PubMed ID: 17197182 [TBL] [Abstract][Full Text] [Related]
40. Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures. de Paula da Silva CH; Bernardes LS; da Silva VB; Zani CL; Carvalho I J Biomol Struct Dyn; 2012; 29(6):702-16. PubMed ID: 22546000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]